EXTON, Pa.--(BUSINESS WIRE)--Adolor Corporation (Nasdaq:ADLR) today announced that it will hold a conference call at 8:30 a.m. ET on Thursday, December 18, 2008 to provide an R&D program update, including its delta agonist and opioid bowel dysfunction (OBD) programs.
